No matches

Dermatology

European Society for Pediatric Dermatology (ESPD) 2024 | Košice, Slovakia

Inflammatory processes drive AD both within and beyond the skin, leading to significant, cumulative life impacts. Early intervention has the potential to mitigate these impacts by altering the disease course.

MD, PhD

Eulàlia Baselga +2 more

Past event

3May2024

Location

House of Arts

Moyzesova 66 040 01 Košice Slovakia

Learning objectives

Explore the ways type 2 inflammation contributes to AD disease pathogenesis within and beyond the skin
Discuss the importance of early intervention in children with AD and the potential for disease modification
Review the latest clinical and real-world data on advanced systemic treatments for infants and preschoolers with AD

Description

Atopic dermatitis is a chronic, inflammatory disease characterized by eczematous skin lesions and intense itch, however, the inflammatory processes underlying AD reach far beyond the skin. Cumulative comorbidities, including other atopic diseases as well as bone and mental health conditions, may result from uncontrolled chronic disease and inflammation both within and beyond the skin in pediatric patients with AD. Development of these extracutaneous health conditions, which may persist into adulthood, can have variable trajectories and contribute to the cumulative life impact of AD.

Join experts Eulàlia Baselga, Amy Paller, and Lisa Weibel as they investigate the inflammatory processes driven by type 2 cytokines that lead to the local and systemic clinical effects of AD. The speakers will discuss the potential benefits of treating children with AD early in the disease process and the emerging clinical and real-world data on the use of advanced systemic treatments for children with AD.

Agenda

Welcome, Objectives, and Audience Polling

Amy Paller (Co-Chair)

Within and Beyond the Skin: New Perspectives on the Role of Type 2 Inflammation in AD

Lisa Weibel

Early Intervention and the Potential for Disease Modification in Children With AD

Amy Paller (Co-Chair)

Emerging Data on Advanced Systemic Treatments for Children With AD

Eulàlia Baselga (Co-Chair)

Conclusions and Live Q&A

All Faculty

The speakers are being compensated and/or receiving honoraria from Sanofi and Regeneron in connection with this program.

Location

House of Arts

Moyzesova 66 040 01 Košice Slovakia

Check on Google Maps

Speakers

Dermatology

MD, PhD

Eulàlia Baselga

Head of the Department of Dermatology, at the Children’s Hospital Sant Joan de Deu, Barcelona, Spain

Dermatology

MD, MS

Amy Paller

Walter J. Hamlin Professor and Chair of Dermatology; Professor of Pediatrics at Northwestern University, Evanston, Illinois, US

Dermatology

Lisa Weibel

Associate Professor | University Children’s Hospital, Zurich, Switzerland

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region

Dermatology

European Society for Pediatric Dermatology (ESPD) 2024 | Košice, Slovakia

MD, PhD

Eulàlia Baselga +2 more

Past event

3May2024

Location

House of Arts

Moyzesova 66 040 01 Košice Slovakia

Learning objectives

Explore the ways type 2 inflammation contributes to AD disease pathogenesis within and beyond the skin
Discuss the importance of early intervention in children with AD and the potential for disease modification
Review the latest clinical and real-world data on advanced systemic treatments for infants and preschoolers with AD

Description

Agenda

Welcome, Objectives, and Audience Polling

Amy Paller (Co-Chair)

Within and Beyond the Skin: New Perspectives on the Role of Type 2 Inflammation in AD

Lisa Weibel

Early Intervention and the Potential for Disease Modification in Children With AD

Amy Paller (Co-Chair)

Emerging Data on Advanced Systemic Treatments for Children With AD

Eulàlia Baselga (Co-Chair)

Conclusions and Live Q&A

All Faculty

The speakers are being compensated and/or receiving honoraria from Sanofi and Regeneron in connection with this program.

Location

House of Arts

Moyzesova 66 040 01 Košice Slovakia

Check on Google Maps

Speakers

Dermatology

MD, PhD

Eulàlia Baselga

Head of the Department of Dermatology, at the Children’s Hospital Sant Joan de Deu, Barcelona, Spain

Dermatology

MD, MS

Amy Paller

Walter J. Hamlin Professor and Chair of Dermatology; Professor of Pediatrics at Northwestern University, Evanston, Illinois, US

Dermatology

Lisa Weibel

Associate Professor | University Children’s Hospital, Zurich, Switzerland